Novartis AG (NVS)
92.58
-0.50
(-0.54%)
USD |
NYSE |
Apr 18, 16:00
92.58
0.00 (0.00%)
After-Hours: 20:00
Novartis Price: 92.58 for April 18, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 17, 2024 | 93.63 | 93.78 | 92.87 | 93.08 | 1.169M |
| Apr 16, 2024 | 92.85 | 93.37 | 92.64 | 93.20 | 1.915M |
| Apr 15, 2024 | 94.20 | 94.96 | 94.11 | 94.41 | 1.501M |
| Apr 12, 2024 | 94.99 | 95.05 | 93.41 | 93.52 | 2.100M |
| Apr 11, 2024 | 94.87 | 94.91 | 93.75 | 94.34 | 1.623M |
| Apr 10, 2024 | 94.57 | 94.67 | 94.04 | 94.38 | 2.399M |
| Apr 09, 2024 | 95.67 | 95.90 | 95.38 | 95.81 | 1.376M |
| Apr 08, 2024 | 95.74 | 96.15 | 95.25 | 95.48 | 1.535M |
| Apr 05, 2024 | 95.30 | 95.93 | 95.13 | 95.79 | 1.917M |
| Apr 04, 2024 | 97.25 | 98.20 | 96.54 | 96.89 | 2.545M |
| Apr 03, 2024 | 94.45 | 94.88 | 94.18 | 94.37 | 1.169M |
| Apr 02, 2024 | 94.64 | 94.64 | 93.92 | 94.41 | 1.469M |
| Apr 01, 2024 | 96.83 | 97.06 | 95.44 | 95.87 | 1.259M |
| Mar 28, 2024 | 96.28 | 97.20 | 96.15 | 96.73 | 1.525M |
| Mar 27, 2024 | 95.50 | 95.90 | 95.27 | 95.88 | 2.432M |
| Mar 26, 2024 | 95.50 | 95.56 | 95.07 | 95.27 | 944216.0 |
| Mar 25, 2024 | 96.15 | 96.29 | 95.73 | 95.73 | 3.642M |
| Mar 22, 2024 | 96.24 | 96.51 | 96.08 | 96.23 | 657587.0 |
| Mar 21, 2024 | 96.40 | 96.79 | 96.04 | 96.08 | 943787.0 |
| Mar 20, 2024 | 95.72 | 96.15 | 95.25 | 96.05 | 935130.0 |
| Mar 19, 2024 | 96.18 | 96.50 | 95.90 | 96.32 | 1.222M |
| Mar 18, 2024 | 96.95 | 97.02 | 95.90 | 95.92 | 1.224M |
| Mar 15, 2024 | 98.18 | 98.32 | 96.69 | 97.27 | 1.541M |
| Mar 14, 2024 | 98.41 | 98.48 | 97.82 | 98.13 | 834449.0 |
| Mar 13, 2024 | 99.70 | 99.79 | 98.86 | 99.00 | 916059.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
70.67
Minimum
Mar 23 2020
108.47
Maximum
Jan 22 2024
89.84
Average
88.48
Median
May 25 2021
Price Benchmarks
| Sandoz Group AG | 31.34 |
| Amgen Inc | 262.71 |
| AstraZeneca PLC | 68.36 |
| Incyte Corp | 52.81 |
| MorphoSys AG | 18.03 |
Price Related Metrics
| PE Ratio | 13.04 |
| PS Ratio | 3.795 |
| PEG Ratio | 0.1045 |
| Price to Book Value | 4.055 |
| Price to Free Cash Flow | 16.54 |
| Earnings Yield | 7.67% |
| Market Cap | 189.23B |
| PEGY Ratio | 0.1012 |
| Operating PE Ratio | 19.13 |
| Normalized PE Ratio | 22.09 |